A detailed history of Guggenheim Capital LLC transactions in Sanofi stock. As of the latest transaction made, Guggenheim Capital LLC holds 7,652 shares of SNY stock, worth $441,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,652
Holding current value
$441,137
% of portfolio
0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$45.39 - $50.36 $347,324 - $385,354
7,652 New
7,652 $371,000
Q1 2023

May 10, 2023

BUY
$45.86 - $54.45 $284,377 - $337,644
6,201 New
6,201 $337,000
Q3 2022

Nov 14, 2022

SELL
$37.22 - $100.5 $288,306 - $778,473
-7,746 Reduced 43.86%
9,913 $377,000
Q2 2022

Aug 15, 2022

SELL
$48.99 - $57.46 $511,700 - $600,169
-10,445 Reduced 37.17%
17,659 $884,000
Q1 2022

May 16, 2022

SELL
$48.48 - $53.65 $189,896 - $210,147
-3,917 Reduced 12.23%
28,104 $1.44 Million
Q4 2021

Feb 14, 2022

SELL
$47.07 - $52.35 $36,667 - $40,780
-779 Reduced 2.38%
32,021 $1.6 Million
Q3 2021

Nov 15, 2021

SELL
$47.89 - $53.12 $12,068 - $13,386
-252 Reduced 0.76%
32,800 $1.58 Million
Q2 2021

Aug 13, 2021

BUY
$49.36 - $54.25 $49,261 - $54,141
998 Added 3.11%
33,052 $1.74 Million
Q1 2021

May 13, 2021

BUY
$45.46 - $50.51 $22,411 - $24,901
493 Added 1.56%
32,054 $1.59 Million
Q4 2020

Feb 16, 2021

BUY
$45.3 - $51.62 $59,750 - $68,086
1,319 Added 4.36%
31,561 $1.53 Million
Q3 2020

Nov 13, 2020

BUY
$49.47 - $53.77 $47,738 - $51,888
965 Added 3.3%
30,242 $1.52 Million
Q2 2020

Aug 14, 2020

BUY
$42.91 - $52.5 $58,829 - $71,977
1,371 Added 4.91%
29,277 $1.5 Million
Q1 2020

Jun 02, 2020

BUY
$38.02 - $51.66 $110,980 - $150,795
2,919 Added 11.68%
27,906 $1.22 Million
Q4 2019

Feb 14, 2020

SELL
$44.25 - $50.86 $184,655 - $212,238
-4,173 Reduced 14.31%
24,987 $1.25 Million
Q3 2019

Nov 14, 2019

SELL
$40.34 - $46.64 $105,852 - $122,383
-2,624 Reduced 8.26%
29,160 $1.35 Million
Q2 2019

Aug 14, 2019

SELL
$40.43 - $44.3 $1.44 Million - $1.58 Million
-35,733 Reduced 52.92%
31,784 $1.38 Million
Q1 2019

May 15, 2019

BUY
$40.83 - $45.43 $8,002 - $8,904
196 Added 0.29%
67,517 $2.99 Million
Q4 2018

Feb 14, 2019

SELL
$41.48 - $45.59 $583,706 - $641,542
-14,072 Reduced 17.29%
67,321 $2.92 Million
Q3 2018

Nov 14, 2018

SELL
$40.0 - $44.84 $158,280 - $177,431
-3,957 Reduced 4.64%
81,393 $3.64 Million
Q2 2018

Aug 14, 2018

SELL
$37.63 - $41.22 $55,654 - $60,964
-1,479 Reduced 1.7%
85,350 $3.42 Million
Q1 2018

May 15, 2018

BUY
$38.98 - $45.76 $752,859 - $883,808
19,314 Added 28.61%
86,829 $3.48 Million
Q4 2017

Feb 14, 2018

BUY
$42.86 - $50.61 $493,361 - $582,571
11,511 Added 20.55%
67,515 $2.9 Million
Q3 2017

Nov 14, 2017

BUY
$47.04 - $50.34 $2.63 Million - $2.82 Million
56,004
56,004 $2.79 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $145B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.